News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
ScreenPro Announces Acquisition of Add Biomedical Inc. and Shares Consolidation
February 23, 2022
·
7 min read
Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules
February 17, 2022
·
5 min read
Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study
February 16, 2022
·
7 min read
Therma Bright Announces CAD$6 Million Private Placement with Institutional Investors
February 16, 2022
·
4 min read
BioHarvest Sciences Inc. Trademarks Its Breakthrough Non-GMO Proven Platform Technology: “BIO-PLANT CELLicitation”
February 16, 2022
·
5 min read
Drug Development
Defence Retains CATO SMS to Advise on Its Phase I Clinical Trial on AccuTOX(TM) for Breast Cancer
February 16, 2022
·
3 min read
Business
ScreenPro Announces Changes to Board of Directors
February 16, 2022
·
4 min read
Marvel Biosciences Announces Proxy Tabulation and Shareholder Meeting Results
February 16, 2022
·
6 min read
Biotech Bay
Cofactor Genomics Publishes Superiority of T Cell State Profiling in Predicting Patient’s Response to Immunotherapy
February 15, 2022
·
1 min read
Therma Bright’s AcuVid(TM) U.S. Clinical Performance Study Successfully Exceeds U.S. Food & Drug Administration’s Emergency Use Authorization Requirements
February 15, 2022
·
6 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us